EV/EBITDA
21.47
-2.03-8.64%
0 min ago
Summary
- As of February 7, 2025, NBIX EV/EBITDA is 21.47, with a fall of -2.03 (-8.64%) during the most recent trading day.
- Over the past year, NBIX EV/EBITDA has dropped by -16.67 (-43.71%).
- NBIX EV/EBITDA is now -96.94% below its all-time high of 702.53.
Performance
NBIX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NBIX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -8.6% | -8.6% | -8.6% |
| 1 m1 month | -10.7% | -10.7% | -10.6% |
| 3 m3 months | -5.5% | -5.5% | -5.5% |
| 6 m6 months | -23.3% | -15.8% | -14.7% |
| ytdytd | -9.0% | -9.0% | -8.9% |
| 1 y1 year | -43.7% | -9.6% | -9.3% |
| 5 y5 years | -81.5% | +23.8% | +18.3% |
NBIX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -20.6% | 21.47 | at low | |
| 3 m | 3-month | 27.03 | -20.6% | 20.44 | +5.0% |
| 6 m | 6-month | 30.08 | -28.6% | 19.31 | +11.2% |
| 1 y | 1-year | 40.97 | -47.6% | 19.31 | +11.2% |
| 3 y | 3-year | 230.58 | -90.7% | 19.31 | +11.2% |
| 5 y | 5-year | 230.58 | -90.7% | 19.31 | +11.2% |
| alltime | all time | 702.53 | -96.9% | -2665 | +100.8% |
Neurocrine Biosciences EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 21.47(-9.0%) |
| 2024 | 23.60(-36.3%) |
| 2023 | 37.06(-23.9%) |
| 2022 | 48.71(-17.8%) |
| 2021 | 59.25(-4.5%) |
| 2020 | 62.03(-48.3%) |
| 2019 | 119.92(+0.3%) |
| 2018 | 119.55(-305.9%) |
| 2017 | -58.07(+150.1%) |
| 2016 | -23.22(-57.5%) |
| 2015 | -54.66(+107.2%) |
| 2014 | -26.38(+121.3%) |
| 2013 | -11.92(-105.8%) |
| 2012 | 205.83(+1598.3%) |
| 2011 | 12.12(-140.8%) |
| Date | Value |
|---|---|
| 2010 | -29.73(+1628.5%) |
| 2009 | -1.72(+81.1%) |
| 2008 | -0.95(+156.8%) |
| 2007 | -0.37(-89.7%) |
| 2006 | -3.58(-97.7%) |
| 2005 | -156.15(+291.3%) |
| 2004 | -39.91(+18.4%) |
| 2003 | -33.70(+148.3%) |
| 2002 | -13.57(-60.0%) |
| 2001 | -33.93(+38.0%) |
| 2000 | -24.59(-15.8%) |
| 1999 | -29.20(+162.1%) |
| 1998 | -11.14(-116.9%) |
| 1997 | 65.83(+47.5%) |
| 1996 | 44.62 |
FAQ
- What is Neurocrine Biosciences EV/EBITDA?
- What is the all time high EV/EBITDA for Neurocrine Biosciences?
- What is NBIX EV/EBITDA year-to-date change?
- What is Neurocrine Biosciences EV/EBITDA year-on-year change?
What is Neurocrine Biosciences EV/EBITDA?
The current EV/EBITDA of NBIX is 21.47
What is the all time high EV/EBITDA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high EV/EBITDA is 702.53
What is NBIX EV/EBITDA year-to-date change?
Neurocrine Biosciences EV/EBITDA has changed by -2.13 (-9.03%) since the beginning of the year
What is Neurocrine Biosciences EV/EBITDA year-on-year change?
Over the past year, NBIX EV/EBITDA has changed by -16.67 (-43.71%)